Moderated by the Chair of the National Science Advisory Board for Biosecurity (NSABB), Paul Keim, Ph.D., this newly added session at the ASM Biodefense and Emerging Diseases Research Meeting includes discussions of the NSABB’s recommendations for the publication of the controversial H5N1 research.
NSABB Recommendations Michael T. Osterholm, Ph.D., MPH University of Minnesota School of Public Health, Minneapolis, MN Director, Center for Infectious Disease Research and Policy (CIDRAP)
Government Response to the Recommendations Anthony S. Fauci, M.D. Director, National Institute of Allergy and Infectious Diseases (NIAID)
Science’s Response to the Situation Bruce Alberts, Ph.D. Editor-in-Chief of Science
Perspective from an Investigator Ron A.M. Fouchier, Ph.D. Erasmus MC, Rotterdam, Netherlands